Global Bronchitis Treatment Market Opportunities And Strategies 2023
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company’s bronchitis treatment market report forecasts the bronchitis treatment market size to grow to $6.60 Billion by 2027, with a CAGR (compound annual growth rate) of almost 6%.
Learn More On The Bronchitis Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/bronchitis-treatment-global-market-report
Bronchitis Treatment Market Size Forecast
The global bronchitis treatment market is expected to grow from $4.96 billion in 2022 to $5.24 billion in 2023 at a compound annual growth rate (CAGR) of 5.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global bronchitis treatment market size is expected to reach $6.60 billion in 2027 at a CAGR of 5.9%.
North America held the largest bronchitis treatment market share.
Key Bronchitis Treatment Market Driver – Increase In The Incidence Of Respiratory Diseases
According to the Bureau of Labour Statistics, a US-based intergovernmental organisation, the number of respiratory disease cases reported by employers grew by about 4,000% in November 2021, from 10,800 in 2019 to 428,700 in 2020, contributing to the increase in illness cases. The number of incidents of respiratory sickness per 10,000 full-time equivalent workers increased from 1.1 in 2019 to 44.0 in 2020. As a result, the rising prevalence of respiratory ailments is propelling the bronchitis treatment market ahead.
Request for A Sample Of The Global Bronchitis Treatment Market Report:
Key Bronchitis Treatment Market Trend – Product Innovations
To maintain their market position, major bronchitis treatment businesses are implementing new technology. Teva Pharmaceutical Industries Ltd., an Israeli pharmaceutical manufacturer, for example, launched the first generic version of PERFOROMIST®, a formoterol fumarate inhalation solution, in June 2021. This solution is designed to treat bronchoconstriction in people with chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema. Adults with COPD can use formoterol fumarate inhalation solution, which is a long-acting beta2-adrenergic agonist (LABA). COPD, a chronic lung disease, may be accompanied by emphysema, chronic bronchitis, or both. Formoterol fumarate inhalation solution can only be used with a nebulizer.
Bronchitis Treatment Market Segment
1) By Type: Acute Bronchitis, Chronic Bronchitis
2) By Treatment: Drugs, Oxygen Therapy
3) By Distribution Channel: Online Pharmaceutical Stores, Retail Pharmacies, Hospital Pharmacies
Bronchitis Treatment Market Major Players and Strategies
Major players in the bronchitis treatment market are AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Dr. Reddy’s Laboratories, Melinta Therapeutics LLC, Sanofi S.A., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Cipla Inc., Merck and Co. Inc., Bayer AG, Johnson & Johnson Private Limited, Viatris Inc., and Lupin Ltd.
Covis Pharma Group, a Swiss specialty pharmaceutical business, paid $270 million for AstraZeneca’s respiratory portfolio of two medications in January 2022. This transaction includes the acquisition of Eklira® and Duaklir®, allowing Covis to provide a comprehensive range of best-in-class treatments for allergic rhinitis, asthma, and COPD (chronic obstructive pulmonary disease), as well as demonstrating its ability to collaborate with and be a preferred partner for major pharmaceutical companies. AstraZeneca PLC is a pharmaceutical and biotechnology business situated in the United Kingdom that is working on a bronchiolitis vaccine.
The Bronchitis Treatment Global Market Report 2023 covers regional data on bronchitis treatment market size, bronchitis treatment market trends and drivers, opportunities, strategies, and bronchitis treatment market competitor analysis. The countries covered in the bronchitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Bronchitis treatment is the treatment of a condition in which the bronchial tubes, which transport air to and from the lungs, become inflamed and create an excess of mucus. Symptom-relieving drugs such as bronchodilators, steroids, and antibiotics are used in this treatment.
View More Reports Related To The Bronchitis Treatment Market –
Polycystic Ovarian Syndrome Treatment Global Market Report 2023
Neutropenia Biologic Drug Treatment Global Market Report 2023
Psoriatic Arthritis Treatment Global Market Report 2023
Follow us on:
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: